title: Artificial Oxygen Carriers: Exactly How Close Are We to an Ultimate Product?
authors.affiliation: Texas HemoBioTherapeutics & BioInnovation Center, Lubbock, TX, USA.
authors.forename: Jan
authors.identifier: http://orcid.org/0000-0001-8099-9341
authors.initials: J
authors.lastname: Simoni
mesh_terms: D000740:Anemia / Q000188:drug therapy / Q000662:veterinary; D000818:Animals; D001802:Blood Substitutes / Q000008:administration & dosage / Q000009:adverse effects / Q000737:chemistry / Q000627:therapeutic use*; D001803:Blood Transfusion; D003692:Delayed-Action Preparations / Q000737:chemistry; D017277:Drug Approval; D006454:Hemoglobins / Q000008:administration & dosage / Q000009:adverse effects / Q000737:chemistry / Q000627:therapeutic use*; D006801:Humans; D010100:Oxygen / Q000378:metabolism; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000009:adverse effects / Q000737:chemistry / Q000627:therapeutic use
chemical_list: D001802:Blood Substitutes; D003692:Delayed-Action Preparations; D006454:Hemoglobins; D011994:Recombinant Proteins; D010100:Oxygen